Dishman Carbogen Amcis (DCAL): Debt restructuring accelerates — board approves Rs 38 Cr fresh NCDs, replaces land mortgage with cash collateral on existing Rs 15 Cr NCDs
On 7 October 2026, Dishman Carbogen Amcis Ltd (NSE: DCAL, BSE: 540701) informed exchanges that its board approved a fresh issue of up to Rs 38 crore in non-convertible debentures and modified the security backing an existing Rs 15 crore NCD tranche allotted just nine days earlier. Both resolutions point to an active debt programme that has moved quickly since the board’s initial August authorisation.
What the 7 October filing disclosed
The exchange filing dated 7 October 2026 states that the board approved issuance of up to 3,800 senior, secured, rated, listed, redeemable, taxable, transferable non-convertible debentures of face value Rs 1,00,000 each, aggregating up to Rs 38 crore, on a private placement basis. The terms are identical to the earlier Tranche II: a 10% per annum coupon payable quarterly, with bullet principal repayment 18 months from allotment. The planned allotment date is 15 October 2026, and the maturity date is 15 April 2028.
The same board resolution modified the security for Tranche II — 1,500 NCDs of face value Rs 1,00,000 each, totalling Rs 15 crore, allotted on 28 September 2026. The original security was a mortgage over land owned by Dishman Infrastructure Limited. The new arrangement replaces that mortgage with “a 100% cash margin FD lien in favour of the Debenture Trustee,” subject to stock exchange approval.
How the programme started — the August 2026 authorisation
The debt raise was first flagged on 12 August 2026, when the board approved issuance of up to 7,500 NCDs of face value Rs 1 lakh each, aggregating up to Rs 75 crore, on a private placement basis. The filing from that date specified a 10% p.a. coupon, payable quarterly, with bullet repayment 18 months from allotment. The expected allotment date was 17 August 2026, with maturity on 17 February 2028. The August filing states the debentures were to be secured by a first-ranking charge on land owned by Dishman Infrastructure Ltd and a corporate guarantee.
The security structure has now been altered for the Tranche II NCDs — from a mortgage over a promoter-group entity’s land to cash collateral deposited with the debenture trustee. The 7 October filing does not state a reason for this change.
Financial results and the context around the raises
The company’s Q1FY27 unaudited consolidated financial results, filed on 14 August 2026, showed a consolidated net loss of ₹57.88 crore, compared to a net profit of ₹21.74 crore in Q4FY26 (the filing names the previous quarter, not the year-ago quarter). Total income from operations for Q1FY27 was ₹677.64 crore, compared to ₹851.40 crore in the preceding quarter.
An earnings call transcript filed on 21 August 2026 added two pieces of context: revenue for Q1FY27 was down 4% year-on-year to ₹677.6 crore, and EBITDA dropped 57% year-on-year. The filing noted the company attributed the decline to order deferral and said it was “working to refinance high-cost debt via a CHF 200M promoter ECB loan.” The filing does not include direct management quotes, so these figures are reported as the company’s presentation summary.
The Swiss subsidiary’s FDA inspection
In a separate filing dated 12 September 2026, the company disclosed that its wholly owned subsidiary CARBOGEN AMCIS AG had “successfully completed a U.S. FDA inspection at its manufacturing site in Vionnaz, Switzerland with no Form 483 issued, meaning zero observations.” The filing does not link the inspection outcome to the subsequent debt activity, but it removes a disclosure item that had been pending.
What the filings show next
The 7 October filing states an allotment date of 15 October 2026 for the fresh Rs 38 crore NCDs, with maturity on 15 April 2028. The security modification for the earlier Rs 15 crore Tranche II is subject to stock exchange approval. The original board authorisation of up to Rs 75 crore, from the 12 August 2026 resolution, leaves headroom beyond the combined Rs 15 crore (Tranche II) and Rs 38 crore (the latest approval). No further tranche dates are disclosed.
Alpha Inflection is research infrastructure, not investment advice. We are not SEBI-registered investment advisers. Everything above is compiled from public corporate filings, with sources cited. Do your own research.
The filing evidence
| Date | What the filing said | Detail | Source |
|---|---|---|---|
| 12 Aug 2026 | Dishman Carbogen Amcis Ltd board approves issue of secured NCDs worth up to Rs 75 crore on a private placement basis. | The board of Dishman Carbogen Amcis Ltd approved the issuance of up to 7,500 senior, secured, rated, listed, redeemable, taxable non-convertible debentures (NCDs) of face value Rs 1 lakh each, aggregating up to Rs 75 crore, on a private placement basis. The NCDs carry a coupon of 10% p.a., payable quarterly, with a bullet repayment at maturity after 18 months from the allotment date (expected allotment August 17, 2026; maturity February 17, 2028). The debentures are secured by a first-ranking charge on land owned by Dishman Infrastructure Ltd and a corporate guarantee. | filing |
| 12 Sept 2026 | Dishman Carbogen Amcis' Swiss subsidiary passes US FDA inspection with zero observations, strengthening quality credentials and removing a regulatory overhang. | The company's wholly owned subsidiary, CARBOGEN AMCIS AG, successfully completed a U.S. FDA inspection at its manufacturing site in Vionnaz, Switzerland with no Form 483 issued, meaning zero observations. | filing |
| 7 Oct 2026 | Dishman Carbogen Amcis board approves Rs 38 crore NCD issue and modifies security of existing Rs 15 crore NCD | Board of Directors approved issuance of up to 3,800 senior, secured, rated, listed, redeemable, taxable, transferable non-convertible debentures of face value Rs 1,00,000 each, aggregating up to Rs 38 crore, on a private placement basis, with 10% p.a. coupon payable quarterly and bullet principal repayment after 18 months. Planned allotment date is 15th October 2026, maturity on 15th April 2028. The board also approved modification of security for the company's Tranche II of 1,500 NCDs (Rs 15 crore), allotted on 28th September 2026, replacing the existing mortgage over land of Dishman Infrastructure Limited with a 100% cash margin FD lien in favour of the Debenture Trustee, subject to stock exchange approval. | filing |
| 14 Aug 2026 | Dishman Carbogen Amcis reports consolidated net loss of Rs 57.88 crore for Q1 FY27 versus net profit of Rs 21.74 crore in Q4 FY26. | Dishman Carbogen Amcis released its Q1 FY27 unaudited financial results, showing a consolidated net loss of Rs 57.88 crore compared to a net profit of Rs 21.74 crore in the previous quarter, with total income from operations falling to Rs 677.64 crore from Rs 851.40 crore. | filing |
| 21 Aug 2026 | Dishman Carbogen Amcis reported a weak Q1FY27 with revenue down 4% YoY to ₹677.6 Cr and EBITDA dropping 57% YoY due to order deferral, while working to refinance high-cost debt via a CHF 200M promoter ECB loan. | filing |
Quick answers
- What did Dishman Carbogen disclose?
- On 7 October 2026, Dishman Carbogen Amcis Ltd (NSE: DCAL, BSE: 540701) informed exchanges that its board approved a fresh issue of up to Rs 38 crore in non-convertible debentures and modified the security backing an existing Rs 15 crore NCD tranche allotted just nine days earlier.
- What are the key numbers?
- The exchange filing dated 7 October 2026 states that the board approved issuance of up to 3,800 senior, secured, rated, listed, redeemable, taxable, transferable non-convertible debentures of face value Rs 1,00,000 each, aggregating up to Rs 38 crore, on a private placement basis.
Research and educational content only. Not investment advice. Drafted from regulatory filings and published automatically — see our editorial policy.